Fatigue · adults with ankylosing spondylitis
1 finding from 1 review
Adverse effects associated with exercises Exercise programme duration: range 3 to 24 weeks · adults with ankylosing spondylitis
It is very uncertain whether exercise programmes changes adverse effects associated with exercises Exercise programme… compared with no intervention (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with ankylosing spondylitis
Exercise programmes showed no clear difference in withdrawals because of adverse events Exercise programme duration:… compared with no intervention (low certainty).
1 finding from 1 review
Physical function · adults with ankylosing spondylitis
1 finding from 1 review
Pain · adults with ankylosing spondylitis
1 finding from 1 review
Quality of life · Adults with symptomatic mild to moderate knee osteoarthritis defined as knee pain and radiographic evidence of non‐end stage…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease response · psoriatic arthritis
Methotrexate may leads to higher disease response compared with placebo (low certainty).
1 finding from 1 review
Health‐related quality of life ‐ not measured · psoriatic arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Disease activity ‐ not measured · psoriatic arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Change in radiographic progression ‐ not measured · psoriatic arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events (leflunomide) assessed by number of events · psoriatic arthritis
1 finding from 1 review
Withdrawals due to adverse events · psoriatic arthritis
2 findings from 1 review
Serious adverse events (ciclosporin A) assessed by number of events · psoriatic arthritis
1 finding from 1 review
Function · psoriatic arthritis
1 finding from 1 review
Health‐related quality of life ‐ not reported · psoriatic arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Disease activity · psoriatic arthritis
1 finding from 1 review
Change in radiographic progression ‐ not measured · psoriatic arthritis
The review found no eligible studies for this question.
1 finding from 1 review
SAEs · psoriatic arthritis
Methotrexate showed no clear difference in serious adverse events (SAEs) assessed by number of events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · psoriatic arthritis
Methotrexate showed no clear difference in withdrawals due to adverse events (WAEs) assessed by number of events compared with placebo (low certainty).
1 finding from 1 review
Disease response (leflunomide) · psoriatic arthritis
It is very uncertain whether methotrexate changes disease response (leflunomide) compared with other DMARDs (very low certainty).
1 finding from 1 review